Literature DB >> 11154994

A pilot study of busulfan, cyclophosphamide and etoposide followed by autologous transplantation for acute myeloid leukemia in remission.

S Bilgrami1, R L Edwards, R D Bona, D Kazierad, F Furlong, J Fox, J Clive, B H Naqvi, P J Tutschka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11154994     DOI： 10.1159/000039751

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  1 in total

1.  European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.

Authors:  B C Medeiros; L Tian; S Robenson; G G Laport; L J Johnston; J A Shizuru; D B Miklos; S Arai; J E Benjamin; W-K Weng; R S Negrin; R Lowsky
Journal:  Blood Cancer J       Date:  2014-05-30       Impact factor: 11.037
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.